Bristol Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Bristol Myers Squibb
BMY Stock  USD 60.66  0.36  0.60%   
Bristol Myers' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bristol Myers' valuation are provided below:
Gross Profit
35 B
Profit Margin
0.1464
Market Capitalization
123.5 B
Enterprise Value Revenue
3.3232
Revenue
48.2 B
We have found one hundred twenty available fundamental signals for Bristol Myers Squibb, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Bristol Myers Squibb prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 108.4 B in 2026. Enterprise Value is likely to rise to about 112.4 B in 2026

Bristol Myers Total Revenue

50.6 Billion

Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 B, Interest Expense of 1.6 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0278 or PTB Ratio of 6.99. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Build AI portfolio with Bristol Stock
Check out the analysis of Bristol Myers Correlation against competitors.

Bristol Myers Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets94.5 B90 B65.3 B
Slightly volatile
Short and Long Term Debt Total49.5 B47.1 B25.5 B
Slightly volatile
Other Current Liabilities17.2 B16.4 B9.4 B
Slightly volatile
Total Current Liabilities24.6 B23.4 B14.8 B
Slightly volatile
Total Stockholder Equity15.2 B18.5 B21 B
Slightly volatile
Property Plant And Equipment Net5.5 B9.1 B5.8 B
Slightly volatile
Retained Earnings21.8 B16.9 B26.7 B
Pretty Stable
Cash5.2 B10.2 B7.4 B
Slightly volatile
Non Current Assets Total63.7 B60.6 B44 B
Slightly volatile
Non Currrent Assets Other1.5 B2.8 B1.5 B
Slightly volatile
Cash And Short Term Investments6.4 B10.7 B8.9 B
Slightly volatile
Net Receivables15.3 B14.5 B8.3 B
Slightly volatile
Good Will22.8 B21.8 B13.3 B
Slightly volatile
Common Stock Shares Outstanding1.6 B2 B1.9 B
Slightly volatile
Liabilities And Stockholders Equity94.5 B90 B65.3 B
Slightly volatile
Non Current Liabilities Total50.5 B48.1 B29.2 B
Slightly volatile
Inventory1.9 B2.7 B1.9 B
Slightly volatile
Other Current Assets1.7 B1.5 B1.9 B
Pretty Stable
Total Liabilities75.1 B71.5 B44 B
Slightly volatile
Property Plant And Equipment Gross15.1 B14.4 B7.7 B
Slightly volatile
Total Current Assets15.4 B29.4 B20.4 B
Slightly volatile
Short Term Debt2.6 B2.5 B1.9 B
Slightly volatile
Intangible Assets20.1 B19.1 B18.1 B
Slightly volatile
Accounts Payable2 B3.6 B2.4 B
Slightly volatile
Common Stock Total Equity255.5 M335.8 M254.7 M
Slightly volatile
Short Term Investments440.8 M464 M1.5 B
Slightly volatile
Capital Stock262.8 M335.8 M255.1 M
Slightly volatile
Common Stock262.8 M335.8 M255.1 M
Slightly volatile
Other Liabilities4.9 B8.5 B6.3 B
Slightly volatile
Other Assets8.6 B8.2 B4 B
Slightly volatile
Long Term Debt45 B42.9 B23.1 B
Slightly volatile
Property Plant Equipment6.2 B9.1 B5.8 B
Slightly volatile
Current Deferred Revenue296.1 M311.6 M1.4 B
Pretty Stable
Retained Earnings Total Equity24.5 B23 B29.2 B
Slightly volatile
Long Term Debt Total23.1 B42.9 B22 B
Slightly volatile
Capital Surpluse48.7 B46.4 B22.6 B
Slightly volatile
Deferred Long Term Liabilities2.2 B2.5 B2.2 B
Slightly volatile
Long Term Investments2 B2.5 B2.5 B
Slightly volatile
Non Current Liabilities Other782.8 M824 M3.6 B
Very volatile
Deferred Long Term Asset Charges557.2 M586.5 M998.5 M
Slightly volatile
Short and Long Term Debt2.7 B2.3 B4.4 B
Slightly volatile
Cash And Equivalents10.8 B10.2 B7.9 B
Slightly volatile
Net Invested Capital70.6 B63.6 B46.2 B
Slightly volatile
Net Working Capital6.4 B6 B6.8 B
Slightly volatile
Capital Lease Obligations1.5 B2 B1.1 B
Slightly volatile

Bristol Myers Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.1 B3.9 B3.7 B
Slightly volatile
Selling General Administrative3.6 B5.7 B3.8 B
Slightly volatile
Total Revenue50.6 B48.2 B30.1 B
Slightly volatile
Gross Profit34.2 B32.6 B19.3 B
Slightly volatile
Other Operating Expenses17.9 B35.5 B22.3 B
Slightly volatile
Operating Income13.3 B12.7 B6.7 B
Slightly volatile
EBITDA15.3 B14.5 B8.6 B
Slightly volatile
Cost Of Revenue16.4 B15.6 B10.8 B
Slightly volatile
Total Operating Expenses10.4 B19.9 B12 B
Slightly volatile
Research Development10.1 B9.6 B6.4 B
Slightly volatile
Selling And Marketing Expenses1.5 B1.6 B4.1 B
Very volatile
Discontinued Operations6 B6.7 B7.3 B
Slightly volatile
Non Recurring2.2 B2.1 B1.7 B
Slightly volatile
Tax Provision1.2 B2.3 B1.2 B
Slightly volatile
Interest Income696.9 M1 B418.9 M
Slightly volatile
Reconciled Depreciation6.9 B4 B4.1 B
Slightly volatile

Bristol Myers Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow13.5 B12.8 B7.7 B
Slightly volatile
Begin Period Cash Flow10.9 B10.3 B7.5 B
Slightly volatile
Depreciation2.2 B4 B3.7 B
Slightly volatile
Capital Expenditures874.7 M1.3 B876.3 M
Slightly volatile
Total Cash From Operating Activities14.9 B14.2 B8.6 B
Slightly volatile
End Period Cash Flow5.4 B10.2 B7.4 B
Slightly volatile
Stock Based Compensation288.4 M553 M388 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.922.28433.7936
Slightly volatile
Dividend Yield0.02780.04580.0315
Slightly volatile
PTB Ratio6.995.95965.3794
Very volatile
Days Sales Outstanding61.711091.7487
Slightly volatile
Book Value Per Share5.789.067111.0251
Pretty Stable
Free Cash Flow Yield0.120.11670.0734
Slightly volatile
Operating Cash Flow Per Share7.286.93584.4199
Slightly volatile
Stock Based Compensation To Revenue0.00910.01150.0114
Pretty Stable
Capex To Depreciation0.310.32690.9344
Slightly volatile
PB Ratio6.995.95965.3794
Very volatile
EV To Sales3.093.05064.2106
Slightly volatile
Free Cash Flow Per Share6.616.29353.9377
Slightly volatile
ROIC0.20.1390.1236
Pretty Stable
Inventory Turnover3.025.79635.0717
Slightly volatile
Days Of Inventory On Hand59.8262.971489.1657
Slightly volatile
Payables Turnover3.14.36143.9861
Slightly volatile
Sales General And Administrative To Revenue0.20.11740.1397
Very volatile
Research And Ddevelopement To Revenue0.140.19940.2072
Very volatile
Capex To Revenue0.04430.02720.0352
Slightly volatile
Cash Per Share5.495.22934.7917
Slightly volatile
POCF Ratio7.397.77717.1223
Slightly volatile
Interest Coverage7.998.407916.8979
Slightly volatile
Capex To Operating Cash Flow0.0880.09260.1595
Slightly volatile
PFCF Ratio8.148.570823.1302
Slightly volatile
Days Payables Outstanding86.2783.6888114
Slightly volatile
EV To Operating Cash Flow9.8710.385818.7382
Slightly volatile
EV To Free Cash Flow22.2811.445825.6745
Slightly volatile
Intangibles To Total Assets0.480.45380.3892
Slightly volatile
Current Ratio1.821.25511.5583
Slightly volatile
Receivables Turnover5.483.3184.1576
Slightly volatile
Graham Number12.6623.8822.3912
Slightly volatile
Shareholders Equity Per Share5.769.05110.9878
Pretty Stable
Debt To Equity2.682.55181.1081
Slightly volatile
Capex Per Share0.330.64230.4622
Slightly volatile
Revenue Per Share24.7923.612915.5791
Slightly volatile
Interest Debt Per Share25.0323.835913.1954
Slightly volatile
Debt To Assets0.550.52350.3219
Slightly volatile
Enterprise Value Over EBITDA12.9810.10819.8869
Very volatile
Short Term Coverage Ratios11.036.26098.3302
Slightly volatile
Operating Cycle221173187
Pretty Stable
Price Book Value Ratio6.995.95965.3794
Very volatile
Days Of Payables Outstanding86.2783.6888114
Slightly volatile
Price To Operating Cash Flows Ratio7.397.77717.1223
Slightly volatile
Price To Free Cash Flows Ratio8.148.570823.1302
Slightly volatile
Operating Profit Margin0.250.26340.226
Pretty Stable
Company Equity Multiplier5.124.8743.0274
Slightly volatile
Long Term Debt To Capitalization0.730.69880.4318
Slightly volatile
Total Debt To Capitalization0.750.71850.4583
Slightly volatile
Return On Capital Employed0.280.19060.168
Pretty Stable
Debt Equity Ratio2.682.55181.1081
Slightly volatile
Ebit Per Revenue0.250.26340.226
Pretty Stable
Quick Ratio1.541.14021.3926
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.182.22721.8349
Slightly volatile
Net Income Per E B T0.660.75610.7882
Slightly volatile
Cash Ratio0.420.4360.546
Pretty Stable
Operating Cash Flow Sales Ratio0.180.29370.2583
Slightly volatile
Days Of Inventory Outstanding59.8262.971489.1657
Slightly volatile
Days Of Sales Outstanding61.711091.7487
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.610.90740.8227
Pretty Stable
Cash Flow Coverage Ratios0.290.30030.5695
Slightly volatile
Price To Book Ratio6.995.95965.3794
Very volatile
Fixed Asset Turnover3.35.28154.6029
Slightly volatile
Capital Expenditure Coverage Ratio11.3410.79799.5957
Slightly volatile
Price Cash Flow Ratio7.397.77717.1223
Slightly volatile
Enterprise Value Multiple12.9810.10819.8869
Very volatile
Debt Ratio0.550.52350.3219
Slightly volatile
Cash Flow To Debt Ratio0.290.30030.5695
Slightly volatile
Price Sales Ratio2.922.28433.7936
Slightly volatile
Asset Turnover0.830.53530.5423
Pretty Stable
Gross Profit Margin0.780.67650.6789
Slightly volatile
Price Fair Value6.995.95965.3794
Very volatile

Bristol Myers Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap108.4 B103.2 B101.7 B
Slightly volatile
Enterprise Value112.4 B107.1 B105.9 B
Slightly volatile

Bristol Fundamental Market Drivers

Forward Price Earnings9.9602
Cash And Short Term Investments10.7 B

Bristol Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue311.6 M296.1 M
Total Revenue48.2 B50.6 B
Cost Of Revenue15.6 B16.4 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.12  0.20 
Research And Ddevelopement To Revenue 0.20  0.14 
Capex To Revenue 0.03  0.04 
Revenue Per Share 23.61  24.79 
Ebit Per Revenue 0.26  0.25 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY